Research, Development, Test and Evaluation, Defense-wide
Schedules
TAFS: 097-0400 2024/2025 - Research, Development, Test and Evaluation, Defense-wide
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $36,886,497,000.00 | See footnotes below | |
| Footnotes for line 1100: | B3: Funds provided by P.L. #118-47 in the amount of $36,892,886,000 MINUS section 8026(e) in the amount of $-6,389,000 signed by the President March 23, 2024. | |||
| 1134 | BA: Disc: Appropriations precluded from obligation | |||
| 1700 | BA: Disc: Spending auth: Collected | $23,624,568.00 | See footnotes below | |
| Footnotes for line 1700: | B4: Per the February 2024 SF-133 | |||
| 1701 | BA: Disc: Spending auth: Chng uncoll pymts Fed src | $278,627,269.00 | See footnotes below | |
| Footnotes for line 1701: | B4: Per the February 2024 SF-133 | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $697,748,163.00 | See footnotes below | |
| Footnotes for line 1740: | B5: Total reimbursable authority matches the budget request for FY2024. B6: Apportioned anticipated budgetary resources, once realized, do not need to be reapportioned unless the amount realized exceeds the conditions on the total amount apportioned (A-11 section 120.49). | |||
| 1920 | Total budgetary resources avail (disc. and mand.) | $37,886,497,000.00 | ||
| 6011 | Lump Sum | $36,886,497,000.00 | ||
| 6012 | Reimbursable | $1,000,000,000.00 | ||
| 6190 | Total budgetary resources available | $37,886,497,000.00 | See footnotes below | |
| Footnotes for line 6190: | A1: A classified attachment displaying the apportionment of specific classified programs within the amount displayed may be included. All documents associated with this apportionment are unclassified except for the Classified Attachment. The classified apportionment shall be allotted in full and executed without change. Such apportionment shall remain valid during the fiscal year until such time as a reapportionment of such classified apportionment is required. Allotments shall be made no later than 30 days after OMB signs the apportionment or the start of the subsequent calendar month, whichever is later. [Rationale: Footnote informs that there may be a classified attachment, and provides other related requirements concerning allotments.] | |||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| A1 | A classified attachment displaying the apportionment of specific classified programs within the amount displayed may be included. All documents associated with this apportionment are unclassified except for the Classified Attachment. The classified apportionment shall be allotted in full and executed without change. Such apportionment shall remain valid during the fiscal year until such time as a reapportionment of such classified apportionment is required. Allotments shall be made no later than 30 days after OMB signs the apportionment or the start of the subsequent calendar month, whichever is later. [Rationale: Footnote informs that there may be a classified attachment, and provides other related requirements concerning allotments.] |
| B3 | Funds provided by P.L. #118-47 in the amount of $36,892,886,000 MINUS section 8026(e) in the amount of $-6,389,000 signed by the President March 23, 2024. |
| B4 | Per the February 2024 SF-133 |
| B5 | Total reimbursable authority matches the budget request for FY2024. |
| B6 | Apportioned anticipated budgetary resources, once realized, do not need to be reapportioned unless the amount realized exceeds the conditions on the total amount apportioned (A-11 section 120.49). |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.